|
Volumn 23, Issue 2, 1996, Pages 329-334
|
Anti-inflammatory drugs and myorelaxants: Pharmacology and clinical use in musculoskeletal disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CARISOPRODOL;
CHLORPHENESIN CARBAMATE;
CHLORZOXAZONE;
CYCLOBENZAPRINE;
DIAZEPAM;
DICLOFENAC;
ETODOLAC;
FENOPROFEN;
FENOPROFEN CALCIUM;
FLURBIPROFEN;
IBUPROFEN;
INDOMETACIN;
KETOPROFEN;
KETOROLAC;
MECLOFENAMATE SODIUM;
MECLOFENAMIC ACID;
MEFENAMIC ACID;
METAXALONE;
METHOCARBAMOL;
MUSCLE RELAXANT AGENT;
NABUMETONE;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ORPHENADRINE;
ORPHENADRINE CITRATE;
OXAPROZIN;
PIROXICAM;
SPASMOLYTIC AGENT;
SULINDAC;
TOLMETIN;
CLINICAL TRIAL;
DROWSINESS;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
GASTROINTESTINAL TOXICITY;
HEADACHE;
HUMAN;
INFLAMMATION;
INTRAMUSCULAR DRUG ADMINISTRATION;
LOW BACK PAIN;
MUSCLE INJURY;
MUSCLE SPASM;
MUSCULOSKELETAL DISEASE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REVIEW;
VERTIGO;
VISUAL IMPAIRMENT;
|
EID: 0030014923
PISSN: 00954543
EISSN: None
Source Type: Journal
DOI: 10.1016/S0095-4543(05)70280-3 Document Type: Article |
Times cited : (17)
|
References (11)
|